Coronavirus: Cancer tests for thousands could be delayed because of NHS supply issues

A breakdown in Roche's distribution warehouse on the South Coast is causing significant disruptions in the supply of vital medical testing materials to the NHS, including COVID-19 tests. This has led to hospitals and GPs having to ration or pause testing, impacting local COVID-19 diagnostics and potentially delaying cancer diagnostics. Roche is working to prioritize the dispatch of COVID-19 tests but has not specified how long the disruption will last. The issue is expected to take weeks to resolve, affecting thousands of patient treatments.

What are the potential consequences of delayed cancer diagnostics mentioned in the text?

What does Roche Diagnostics prioritize in their dispatch to the NHS?